EnsiliTech (private company)

See something wrong or missing? Let us know
Offices:Bath
Business model:B2B

EnsiliTech is a British biopharmaceuticals company that developed a platform technology – ensilication – that can be applied to both existing and new biopharmaceuticals to make them safe and stable at room temperatures.

Investors: we tracked 9 investors

You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

values in USD

Investments 7.56M


You need an account to access this feature. Log in or create one from here.

Do you have a question? Talk to us.

Companies with similar profile to EnsiliTech

Name Criteria
Denmark Octarine Bio
67%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
United Kingdom PharmEnable
67%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
United Kingdom CardiaTec Biosciences
67%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 4
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
Germany Probably Genetic
67%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 1
  • Total raised in a similar range: 5M - 10M USD
Sweden Inossia
63%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
France PEP-Therapy
63%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 2
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Carcinotech
63%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 3
  • At least one vc investor: found 2
  • At least one other investor: found 2
  • Total raised in a similar range: 5M - 10M USD
United Kingdom Beckley Psytech
62%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 4
  • At least one other investor: found 2
France Synapse Medicine
62%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 2
Sweden Trialbee
62%
  • Similar verticals: Health services, Pharma
  • Similar business models: B2B
  • At least one angel investor: found 1
  • At least one vc investor: found 3
  • At least one other investor: found 1
Top